For physicians and providers working in multiple medical disciplines, RFPi’s proprietary iCertainty™ platform imaging technology could have an important impact.

This includes any medical procedure where blood flow and/or perfusion physiology or pathophysiology might affect the provider’s decision-making, or the technical aspects of the procedures.

The iCertainty technology is readily adaptable for open and lesser-invasive (scope-based, robotic) surgical approaches.

Since iCertainty is all digital imaging data, in addition to real-time analysis, it could provide unique information for decision support, for data exchange at transfers, for direct incorporation into EHRs, and and for overall safety and continuity of care across a broad array of providers and healthcare settings.

In addition, the ability of iCertainty to deliver real-time documentation of the adequacy of flow and perfusion following procedures promises to be a novel, imaging-based and quantifiable quality metric for these procedures.

To date, the iCertainty device has not yet received FDA clearance. Medical applications anticipated to be prime candidates for RFPi's proprietary medical imaging technologies include:
  • Foregut and Gastrointestinal surgeries
  • Vascular Surgeries and Wound Management
  • Cardiothoracic Surgeries
  • Plastic and Reconstructive Surgeries
  • Transplant Surgeries
  • Burn Therapies
  • Monitoring (Hemodynamic and Physiologic)
RFPi, LLC is developing partnerships with industry and the military for certain of these clinical and monitoring applications of this platform technology.
Back To Top